100 Participants Needed

Animal vs. Plant Proteins for Diabetes

(HP Trial)

Recruiting at 1 trial location
BM
Overseen ByBETTINA MITTENDORFER
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Missouri-Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial requires that you do not take medications known to affect the study outcomes. If you are on such medications, you may need to stop them to participate.

What data supports the effectiveness of the treatment 'Animal vs. Plant Proteins for Diabetes'?

Research shows that replacing animal protein with plant protein can modestly improve blood sugar control in people with diabetes. Plant-based diets, which include whole grains, nuts, and soy, may also help manage diabetes and reduce the risk of kidney problems.12345

Is it safe to consume high animal or plant protein diets for diabetes?

Research suggests that replacing animal protein with plant protein may improve blood sugar control in people with diabetes and could reduce the risk of developing type 2 diabetes. However, care should be taken to ensure nutritional balance, especially with plant proteins, as they may have lower bioavailability (how well nutrients are absorbed) compared to animal proteins.56789

How does the treatment of replacing animal protein with plant protein differ from other diabetes treatments?

This treatment is unique because it focuses on replacing animal protein with plant protein in the diet, which has shown modest improvements in blood sugar control for people with diabetes. Unlike traditional diabetes treatments that often involve medication, this approach emphasizes dietary changes to manage the condition.2561011

What is the purpose of this trial?

The goal of this proposal is to determine the effect of a high protein diet in which the increase in protein intake is derived from different sources (animal vs plant and protein-rich whole foods vs protein isolates) on: i) liver and muscle insulin sensitivity; ii) the metabolic response to a meal, and iii) 24-h plasma concentration profiles of glucose, glucoregulatory hormones, and protein-derived metabolites purported to cause metabolic dysfunction.

Research Team

BM

Bettina Mittendorfer

Principal Investigator

University of Missouri-Columbia

Eligibility Criteria

This trial is for adults aged 21-70 with a BMI between 24.5 and 32.5, who consume low protein diets and exercise minimally. Participants should be weight stable without significant organ dysfunction, chronic kidney disease, or metabolic conditions like diabetes. They must not have allergies to the study foods, take certain supplements or medications affecting the outcomes, be vegetarians/vegans, use tobacco excessively or drink alcohol.

Inclusion Criteria

BMI: >24.5 and <32.5 kg/m2;
habitual protein intake <0.9 g/kg/day (assessed on 2 weekdays and 2 weekend days by using the HealthWatch 360 app); and
I am between 21 and 70 years old.
See 1 more

Exclusion Criteria

I have prediabetes or type 2 diabetes.
You drink more alcohol than recommended (more than 14 drinks per week for women or more than 21 drinks per week for men) or use tobacco products.
I do not have major organ system diseases like cirrhosis.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Dietary Intervention

Participants follow a high protein diet with protein intake from different sources (animal vs plant and protein-rich whole foods vs protein isolates) to assess effects on insulin sensitivity and metabolic response.

8-12 weeks

Follow-up

Participants are monitored for safety and effectiveness after dietary intervention

4 weeks

Treatment Details

Interventions

  • High animal protein isolate
  • High animal protein whole food
  • High plant protein isolate
  • High plant protein whole food
Trial Overview The study examines how high-protein diets from different sources (animal vs plant-based; whole foods vs isolates) affect insulin sensitivity in liver and muscle, response to meals, and daily levels of glucose and hormones related to metabolism. It aims to understand if these proteins can influence metabolic health differently.
Participant Groups
5Treatment groups
Experimental Treatment
Active Control
Group I: High plant protein whole foodExperimental Treatment1 Intervention
Group II: High plant protein isolateExperimental Treatment1 Intervention
Group III: High animal protein whole foodExperimental Treatment1 Intervention
Group IV: High animal protein isolateExperimental Treatment1 Intervention
Group V: Standard protein (control)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Missouri-Columbia

Lead Sponsor

Trials
387
Recruited
629,000+

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+

Findings from Research

A low-protein diet (0.8 g/kg) may help individuals with diabetes who are experiencing macroalbuminuria, which is a sign of kidney damage.
Preliminary evidence indicates that vegetable proteins could be safely used to supplement or replace animal proteins without harming kidney function.
Protein, diabetes, and nephropathy.Franz, MJ.[2017]
In a study of eight patients with Type 1 diabetes and high albumin excretion rates, switching to a predominantly vegetarian diet for 8 weeks significantly reduced albumin excretion, indicating potential benefits for kidney health.
The reduction in albumin excretion was achieved without significantly altering total protein intake, and there were no adverse effects on blood glucose control or blood pressure, suggesting that a vegetarian diet could be a safe and effective dietary intervention for diabetic nephropathy.
Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status.Jibani, MM., Bloodworth, LL., Foden, E., et al.[2022]
In a study of nine normotensive type I diabetic patients, a vegetable protein diet (VPD) resulted in lower glomerular filtration rate (GFR) and renal plasma flow (RPF) compared to an animal protein diet (APD), indicating that the type of protein consumed can affect kidney function.
The VPD led to higher renal vascular resistance and lower fractional clearance of albumin, suggesting that the renal effects of plant-based proteins differ significantly from those of animal proteins, potentially due to variations in amino acid profiles and insulin-like growth factor I (IGF-I) levels.
Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients.Kontessis, PA., Bossinakou, I., Sarika, L., et al.[2019]

References

Protein, diabetes, and nephropathy. [2017]
Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. [2022]
Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. [2019]
Type 2 diabetes and the vegetarian diet. [2018]
Effect of Replacing Animal Protein with Plant Protein on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2023]
Protein should be added to dietary advice on diabetes. [2019]
Protein content and amino acid composition in the diet of Danish vegans: a cross-sectional study. [2023]
Quality and Quantity of Protein Intake Influence Incidence of Type 2 Diabetes Mellitus in Coronary Heart Disease Patients: From the CORDIOPREV Study. [2021]
Animal versus plant-based protein and risk of cardiovascular disease and type 2 diabetes: a systematic review of randomized controlled trials and prospective cohort studies. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus. [2019]
Protein and vegetarian diets. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security